Pediatric septic shock and multiple organ failure

Related Experiment Video

Updated: Sep 23, 2026

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

Joseph A Carcillo1

  • 1Division of Critical Care Medicine, Children's Hospital of Pittsburgh, 3705 5th Avenue, Pittsburgh, PA 15123, USA. carcilloja@ccm.upmc.edu

Critical Care Clinics
|July 10, 2003
PubMed

Insights

Recent advances in pediatric sepsis, septic shock, and organ failure have improved understanding and reduced mortality. This review updates key findings from the last five years, focusing on successful randomized trials in children and newborns.

Area of Science:

  • Critical Care Medicine
  • Pediatric Infectious Diseases
  • Neonatology

Background:

  • Significant progress in understanding pediatric sepsis, septic shock, and multiple organ failure over the past five years.
  • Previous foundational knowledge established by 1997 reviews on septic shock.

Purpose of the Study:

  • To review and synthesize recent advances in pediatric sepsis, septic shock, and multiple organ failure.
  • To update the understanding based on new epidemiological data and pathogenesis insights.
  • To highlight successful randomized trials and their impact on mortality reduction.

Main Methods:

  • Literature review of studies published within the last five years.
  • Analysis of randomized controlled trials focusing on pediatric sepsis, septic shock, and organ failure.
  • Synthesis of data on epidemiology, pathogenesis, and treatment outcomes.

Main Results:

  • Substantial increase in successful randomized trials demonstrating reduced mortality in adults, children, and newborns.
  • Enhanced understanding of the epidemiology and pathogenesis of pediatric sepsis and related conditions.
  • Evidence-based updates on management strategies for pediatric septic shock and organ failure.

Conclusions:

  • The field has seen significant advancements in the last five years, leading to improved outcomes.
  • Successful randomized trials have provided critical evidence for reducing mortality in pediatric sepsis.
  • This review provides a contemporary update on pediatric sepsis management and research.

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.